Mayne Pharma | Ordinære Aksjekapital



Ordinary Share Capital Endring Dato
Ansell USD 1.03B 305.2M 2024-06
Cochlear AUD 1.2B 0 2024-06
CSL USD 557M 20M 2024-06
Ecofibre AUD 120.81M 134K 2024-06
Healius AUD 2.6B 100K 2024-12
Integral Diagnostics AUD 335.09M 1.07M 2024-06
Medical Developments International AUD 105.73M 0 2024-06
Nanosonics AUD 114.54M 167K 2024-06
Next Science USD 133.83M 2.59K 2024-06
Polynovo AUD 191.6M 0 2024-06
Ramsay Health Care AUD 2.27B 19.6M 2024-12
ResMed USD 760K 2K 2024-12
Sigma Healthcare AUD 1.64B 43.99M 2024-07
Sonic Healthcare AUD 4.15B 467K 2024-12
Telix Pharmaceuticals AUD 587.41M 141.14M 2024-06



Mayne Pharma Ordinære Aksjekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.